Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120

Biochemical and Biophysical Research Communications

Volumn 316, Issue 1, 2004, Pages 203-210

  Chiba, Harumi ^a   Inokoshi, Junji ^a   Nakashima, Hideki ^b   Omura, Satoshi ^a   Tanaka, Haruo ^a  

^a KITASATO UNIVERSITY   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINOHIVIN; CARBOHYDRATE; CD4 ANTIGEN; CONCANAVALIN A; ENVELOPE PROTEIN; GLYCOPROTEIN GP 120; MANNAN; MANNOSE; RIBONUCLEASE; THYROGLOBULIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ACTINOMYCES; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; IC 50; LONGISPORA ALBIDA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RABBIT; SHEEP; SIMIAN IMMUNODEFICIENCY VIRUS; YEAST;

ACTINOBACTERIA; ANTI-HIV AGENTS; BACTERIAL PROTEINS; BINDING SITES; BIOLOGICAL TRANSPORT; CELL LINE; CHEMOKINES, CXC; GIANT CELLS; GLYCOPROTEINS; HELA CELLS; HEMAGGLUTINATION; HIV; HIV ENVELOPE PROTEIN GP120; HUMANS; MANNOSE; RECEPTORS, CXCR4; RECEPTORS, VIRUS; VIRAL PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; LONGISPORA ALBIDA; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; UNCULTURED ACTINOMYCETE;

EID: 1542345753     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.02.036     Document Type: Article

References (24)

1. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272:1996;872-877.
2. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., Berger E.A. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 272:1996;1955-1958.
3. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., Davis C.B., Peiper S.C., Schall T.J., Littman D.R., Landau N.R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
4. Dragic T., Litwin V., Allaway G.P., Martin S.R., Huang Y., Nagashima K.A., Cayanan C., Maddon P.J., Koup R.A., Moore J.P., Paxton W.A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667-673.
5. Chan D.C., Kim P.S. HIV entry and its inhibition. Cell. 93:1998;681-684.
6. Doms R.W., Moore J.P. HIV-1 membrane fusion: targets of opportunity. J. Cell Biol. 151:2000;F9-F14.
7. Chiba H., Asanuma S., Okamoto M., Inokoshi J., Tanaka H., Fujita K., Omura S. A simple screening system for anti-HIV drugs: syncytium formation assay using T-cell line tropic and macrophage tropic HIV env expressing cell lines - establishment and validation. J. Antibiot. 54:2001;818-826.
8. Chiba H., Inokoshi J., Okamoto M., Asanuma S., Matsuzaki K., Iwama M., Mizumoto K., Tanaka H., Oheda M., Fujita K., Nakashima H., Shinose M., Takahashi Y., Omura S. Actinohivin, a novel anti-HIV protein from an actinomycete that inhibits syncytium formation: isolation, characterization, and biological activities. Biochem. Biophys. Res. Commun. 282:2001;595-601.
9. Matsumoto A., Takahashi Y., Shinose M., Iwai Y., Omura S. Longispora albida gen. nov., sp. nov., a novel genus of the family Micromonosporaceae. Int. J. Syst. Evol. Microbiol. 53:2003;1553-1559.
10. Inokoshi J., Chiba H., Asanuma S., Takahashi A., Omura S., Tanaka H. Molecular cloning of actinohivin, a novel anti-HIV protein from an actinomycete, and its expression in Escherichia coli. Biochem. Biophys. Res. Commun. 281:2001;1261-1265.
11. Kimpton J., Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 66:1992;2232-2239.
12. Astoul C.H., Peumans W.J., Van Damme E.J., Roug P. Accessibility of the high-mannose glycans of glycoprotein gp120 from human immunodeficiency virus type 1 probed by in vitro interaction with mannose-binding lectins. Biochem. Biophys. Res. Commun. 274:2000;455-460.
13. Chakrabarti L., Guyader M., Alizon M., Daniel M.D., Desrosiers R.C., Tiollais P., Sonigo P. Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature. 328:1987;543-547.
14. Leonard C.K., Spellman M.W., Riddle L., Harris R.J., Thomas J.N., Gregory T.J. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265:1990;10373-10382.
15. Rawitch A.B., Pollock H.G., Yang S.X. Thyroglobulin glycosylation: location and nature of the N-linked oligosaccharide units in bovine thyroglobulin. Arch. Biochem. Biophys. 300:1993;271-279.
16. Guttman A., Pritchett T. Capillary gel electrophoresis separation of high-mannose type oligosaccharides derivatized by 1-aminopyrene-3,6,8- trisulfonic acid. Electrophoresis. 16:1995;1906-1911.
17. Tai T., Yamashita K., Ogata-Arakawa M., Koide N., Muramatsu T., Iwashita S., Inoue Y., Kobata A. Structural studies of two ovalbumin glycopeptides in relation to the endo-beta-. N -acetylglucosaminidase specificity J. Biol. Chem. 250:1975;8569-8575.
18. Bewley C.A., Otero-Quintero S. The potent anti-HIV protein cyanovirin-N contains two novel carbohydrate binding sites that selectively bind to Man(8) D1D3 and Man(9) with nanomolar affinity: implications for binding to the HIV envelope protein gp120. J. Am. Chem. Soc. 123:2001;3892-3902.
19. Boyd M.R., Gustafson K.R., McMahon J.B., Shoemaker R.H., O'Keefe B.R., Mori T., Gulakowski R.J., Wu L., Rivera M.I., Laurencot C.M., Currens M.J., Cardellina 2nd Jh., Buckheit Rw. Jr., Nara P.L., Pannell L.K., Sowder 2nd Rc., Henderson L.E. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob. Agents Chemother. 41:1997;1521-1530.
20. Geijtenbeek T.B., Kwon D.S., Torensma R., van Vliet S.J., van Duijnhoven G.C., Middel J., Cornelissen I.L., Nottet H.S., KewalRamani V.N., Littman D.R., Figdor C.G., van Kooyk Y. DC-SIGN, a dendritic cell-specific HIV-1 binding protein that enhances trans-infection of T cells. Cell. 100:2000;587-597.
21. Pohlmann S., Baribaud F., Doms R.W. DC-SIGN and DC-SIGNR: helping hands for HIV. Trends Immunol. 22:2001;643-646.
22. Feinberg H., Mitchell D.A., Drickamer K., Weis W.I. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science. 294:2001;2163-2166.
23. Lin G., Simmons G., Pohlmann S., Baribaud F., Ni H., Leslie G.J., Haggarty B.S., Bates P., Weissman D., Hoxie J.A., Doms R.W. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J. Virol. 77:2003;1337-1346.
24. Barrientos L.G., O'Keefe B.R., Bray M., Sanchez A., Gronenborn A.M., Boyd M.R. Cyanovirin-N binds to the viral surface glycoprotein, GP(1,2) and inhibits infectivity of Ebola virus. Antiviral Res. 58:2003;47-56.